Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs

Vaccine

Volumn 27, Issue 50, 2009, Pages 7021-7026

  Stiasny, Karin ^a   Holzmann, Heidemarie ^a   Heinz, Franz X ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anamnestic immune response; Tick borne encephalitis virus; Vaccination breakthrough

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; TICK BORNE ENCEPHALITIS VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TICK BORNE ENCEPHALITIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; VIRAL VACCINES; YOUNG ADULT;

EID: 70350567799     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.069     Document Type: Article

References (45)

1. WHO. Immunization against diseases of public health importance (2005), World Health Organization (WHO) [Fact sheet N°228]
2. Plotkin S.L., and Plotkin S.A. A short history of vaccination. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines (2008), Saunders Elsevier 1-36
3. Jefferson T.O., Rivetti D., Di Pietrantonj C., Rivetti A., and Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2 (2007) CD001269
4. Fiore A.E., Feinstone S.M., and Bell B.P. Hepatitis A vaccines. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines (2008), Saunders Elsevier 177-203
5. Zuckerman J.N. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol 78 2 (2006) 169-177
6. Banatvala J.E., and Van Damme P. Hepatitis B vaccine-do we need boosters?. J Viral Hepat 10 1 (2003) 1-6
7. Strebel P.M., Papania M.J., Dayan G.H., and Halsey N.A. Measles vaccine. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines (2008), Saunders Elsevier 353-398
8. Halstead S.B., and Jacobson J. Japanese encephalitis vaccines. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines (2008), Saunders Elsevier 311-352
9. Monath T.P., Cetron M.S., and Teuwen D.E. Yellow fever vaccine. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines (2008), Saunders Elsevier 959-1055
10. Heinz F.X., Holzmann H., Essl A., and Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 25 43 (2007) 7559-7567
11. Thiel H.J., Collett M.S., Gould E.A., Heinz F.X., Houghton M., Meyers G., et al. Family Flaviviridae. In: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball L.A. (Eds). Virus Taxonomy. VIIIth Report of the International Committee on Taxonomy of Viruses (2005), Elsevier Academic Press, San Diego 981-998
12. Ecker M., Allison S.L., Meixner T., and Heinz F.X. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 80 Pt 1 (1999) 179-185
13. Gubler D., Kuno G., and Markhoff L. Flaviviruses. In: Knipe D.M., Howley P.M., Griffin D.E., et al. (Eds). Fields virology (2006), Lippincott. Williams & Wilkins, Philadelphia 1153-1252
14. Lindquist L., and Vapalahti O. Tick-borne encephalitis. Lancet 371 9627 (2008) 1861-1871
15. Donoso Mantke O., Schadler R., and Niedrig M. A survey on cases of tick-borne encephalitis in European countries. Euro Surveill 13 17 (2008)
16. Haglund M., and Gunther G. Tick-borne encephalitis-pathogenesis, clinical course and long-term follow-up. Vaccine 21 Suppl 1 (2003) S11-18
17. Holzmann H. Diagnosis of tick-borne encephalitis. Vaccine 21 Suppl 1 (2003) S36-40
18. Barrett P.N., Plotkin S.A., and Ehrlich H.J. Tick-borne encephalitis virus vaccines. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines (2008), Saunders Elsevier 841-856
19. Gunther G., Haglund M., Lindquist L., Skoldenberg B., and Forsgren M. Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome. Clin Diagn Virol 8 1 (1997) 17-29
20. Kaiser R., and Holzmann H. Laboratory findings in tick-borne encephalitis-correlation with clinical outcome. Infection 28 2 (2000) 78-84
21. Kunz C. TBE vaccination and the Austrian experience. Vaccine 21 Suppl 1 (2003) S50-55
22. Bender A., Jager G., Scheuerer W., Feddersen B., Kaiser R., and Pfister H.W. Two severe cases of tick-borne encephalitis despite complete active vaccination-the significance of neutralizing antibodies. J Neurol 251 3 (2004) 353-354
23. Kleiter I., Jilg W., Bogdahn U., and Steinbrecher A. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination. Infection 35 1 (2007) 26-29
24. Lotric-Furlan S., Avsic-Zupanc T., and Strle F. Tick-borne encephalitis after active immunization. Int J Med Microbiol 298 Suppl 1 (2008) 309-313
25. Mandl C.W., Heinz F.X., and Kunz C. Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology 166 1 (1988) 197-205
26. Mandl C.W., Heinz F.X., Stockl E., and Kunz C. Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. Virology 173 1 (1989) 291-301
27. Heinz F.X., and Kunz C. Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J Gen Virol 57 Pt 2 (1981) 263-274
28. Heinz F.X., Roggendorf M., Hofmann H., Kunz C., and Deinhardt F. Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tick-borne encephalitis virus in serum and cerebrospinal fluid. J Clin Microbiol 14 2 (1981) 141-146
29. Hofmann H., Kunz C., Heinz F.X., and Dippe H. Detectability of IgM antibodies against TBE virus after natural infection and after vaccination. Infection 11 3 (1983) 164-166
30. Stiasny K., Kiermayr S., Holzmann H., and Heinz F.X. Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol 80 19 (2006) 9557-9568
31. Holzmann H., Kundi M., Stiasny K., Clement J., McKenna P., Kunz C., et al. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol 48 1 (1996) 102-107
32. Hadler S.C., Dietz V., Okwo-Bele J.M., and Cutts F.T. Immunization in developing countries. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines (2008), Saunders Elsevier 1541-1571
33. Graham B.S., and Crowe J.E. Immunization against viral diseases. In: Knipe D.M., Howley P.M., Griffin D.E., et al. (Eds). Fields virology (2006), Lippincott. Williams & Wilkins, Philadelphia 487-538
34. Pollard A.J., Perrett K.P., and Beverley P.C. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol 9 3 (2009) 213-220
35. Auckland C., Gray S., Borrow R., Andrews N., Goldblatt D., Ramsay M., et al. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J Infect Dis 194 12 (2006) 1745-1752
36. Pannuti C.S., Morello R.J., Moraes J.C., Curti S.P., Afonso A.M., Camargo M.C., et al. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic. Clin Diagn Lab Immunol 11 1 (2004) 119-122
37. Park D.W., Nam M.H., Kim J.Y., Kim H.J., Sohn J.W., Cho Y., et al. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine 25 24 (2007) 4665-4670
38. Edmonson M.B., Addiss D.G., McPherson J.T., Berg J.L., Circo S.R., and Davis J.P. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 263 18 (1990) 2467-2471
39. Ozanne G., and d'Halewyn M.A. Secondary immune response in a vaccinated population during a large measles epidemic. J Clin Microbiol 30 7 (1992) 1778-1782
40. Schosser R., Kaiser R., Mansmann U., and Heininger U. How to re-establish seroprotection in travellers with a history of incomplete and/or irregular TBE vaccination. 11th Conference of the International Society of Travel Medicine (CISTM11). Budapest (2009)
41. Gassmann C., and Bauer G. Avidity determination of IgG directed against tick-borne encephalitis virus improves detection of current infections. J Med Virol 51 3 (1997) 242-251
42. Saksida A., Duh D., Lotric-Furlan S., Strle F., Petrovec M., and Avsic-Zupanc T. The importance of tick-borne encephalitis virus RNA detection for early differential diagnosis of tick-borne encephalitis. J Clin Virol 33 4 (2005) 331-335
43. Zinkernagel R.M., and Hengartner H. Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory'. Immunol Rev 211 (2006) 310-319
44. Kreil T.R., and Eibl M.M. Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model. J Virol 71 4 (1997) 2921-2927
45. Morrey J.D., Siddharthan V., Olsen A.L., Roper G.Y., Wang H., Baldwin T.J., et al. Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. J Infect Dis 194 9 (2006) 1300-1308